Remove 2022 Remove Disease Remove Hospital Remove Radiation Oncology
article thumbnail

ASTRO and ESTRO Issue Clinical Guideline on Local Therapy for Oligometastatic Lung Cancer

Imaging Technology

The guideline is published in Practical Radiation Oncology. The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor.

article thumbnail

Advances from MSK Researchers Reported at 2023 ASTRO Meeting

Imaging Technology

At the meeting, held from October 1 to October 4, 2023, in San Diego, Simon Powell, MD, PhD, FRCP , Chair of MSK’s Department of Radiation Oncology and Enid A. Haupt Chair in Radiation Oncology, was honored with ASTRO’s Gold Medal Award. It is caused by an inherited mutation in the gene TP53.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. When, in 2022, the U.S. However, few freestanding theranostics centers exist today.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

article thumbnail

The rise of theranostics: Part 3 -- What is a theranostics center?

AuntMinnie

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

article thumbnail

ASTRO Issues Patient-centered Clinical Guideline on Partial Breast Irradiation for Early-stage Invasive Breast Cancer and DCIS

Imaging Technology

milla1cf Mon, 11/20/2023 - 12:49 November 20, 2023 — The American Society for Radiation Oncology (ASTRO) issued a clinical guideline on partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ ( DCIS ).